6.17 : Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking neurotransmitter release and uptake by targeting the catecholamine transporter NET. It can also enter synaptic vesicles and displace noradrenaline. Some other drugs like duloxetine, imipramine, and cocaine also inhibit this transporter. Cocaine, in particular, enhances sympathetic activity by obstructing the reuptake of catecholamines. While these drugs have been studied experimentally, only a few have been used clinically. Newer and more selective drugs have made some of these compounds outdated. However, understanding how these drugs affect the release and reuptake of catecholamines is essential for potential treatments of various disorders.
Aus Kapitel 6:
Now Playing
6.17 : Drugs Affecting Neurotransmitter Release or Uptake
Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents
886 Ansichten
6.1 : Adrenerge Neuronen: Neurotransmission
Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents
3.2K Ansichten
6.2 : Adrenerge Rezeptoren (Adrenozeptoren): Klassifikation
Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents
2.1K Ansichten
6.3 : Adrenerge Rezeptoren: ɑ Subtyp
Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents
1.3K Ansichten
6.4 : Adrenerge Rezeptoren: β Subtyp
Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents
1.4K Ansichten
6.5 : Adrenerge Agonisten: Direkt wirkende Wirkstoffe
Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents
1.3K Ansichten
6.6 : Adrenerge Agonisten: indirekt wirkende Agenzien
Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents
1.4K Ansichten
6.7 : Adrenerge Agonisten: Mixed-Action-Wirkstoffe
Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents
631 Ansichten
6.8 : Adrenerge Agonisten: Chemie und Struktur-Wirkungs-Beziehung
Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents
2.5K Ansichten
6.9 : Adrenerge Agonisten: Therapeutische Klassifikation
Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents
650 Ansichten
6.10 : Adrenerge Agonisten: Therapeutische Anwendungen
Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents
693 Ansichten
6.11 : Adrenerge Antagonisten: Chemie und Klassifikation von ɑ-Rezeptorblockern
Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents
767 Ansichten
6.12 : Adrenerge Antagonisten: Pharmakologische Wirkungen von ɑ-Rezeptor-Blockern
Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents
514 Ansichten
6.13 : Adrenerge Antagonisten: Chemie und Klassifikation von β-Rezeptor-Blockern
Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents
472 Ansichten
6.14 : Adrenerge Antagonisten: Pharmakologische Wirkungen von β-Rezeptor-Blockern
Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents
501 Ansichten
See More
Copyright © 2025 MyJoVE Corporation. Alle Rechte vorbehalten